Search research articles
Contact Us
Filters
Showing results (1-10 of 20) with videos related to
Page
of 2
Sort By:
Memo
|
April 19, 2022
Agony of choice-selecting chronic lymphocytic leukemia treatment in 2022
Jan-Paul Bohn
Memo
|
September 18, 2018
Current and evolving treatment strategies in adult immune thrombocytopenia
Jan-Paul Bohn, Michael Steurer
Current Oncology Reports
|
September 8, 2023
Next-Generation Sequencing-Optimal Sequencing of Therapies in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
Florian Simon, Jan-Paul Bohn
Cancers
|
February 25, 2022
Treatment of Classic Hairy Cell Leukemia: Targeting Minimal Residual Disease beyond Cladribine
Jan-Paul Bohn, Sascha Dietrich
Memo
|
July 19, 2016
Long-term treatment of hairy cell leukemia with interferon-α: still a viable therapeutic option
Jan-Paul Bohn, Guenther Gastl, Michael Steurer
Targeted Oncology
|
January 30, 2016
Targeted Therapies for the Treatment of Brain Metastases in Solid Tumors
Jan-Paul Bohn, Georg Pall, Guenther Stockhammer, et al.
International Journal of Molecular Sciences
|
August 7, 2021
The Biology of Classic Hairy Cell Leukemia
Jan-Paul Bohn, Stefan Salcher, Andreas Pircher, et al.
Cancers
|
March 10, 2022
Hairy Cell Leukemia Patients Have a Normal Life Expectancy-A 35-Year Single-Center Experience and Comparison with the General Population
Jan-Paul Bohn, Sabrina Neururer, Markus Pirklbauer, et al.
Therapeutic Advances in Hematology
|
August 4, 2022
Major cardiac surgery with recombinant FIX Fc fusion protein replacement in hemophilia B: a case report
Jan-Paul Bohn, Anna Fiala, Sebastian Bachmann, et al.
Leukemia & Lymphoma
|
August 21, 2024
Reduced prognostic value of beta-2-microglobulin for time to first treatment in CLL patients with compromised kidney function
Jan-Paul Bohn, Valentina Stolzlechner, Georg Göbel, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 20) with videos related to
Sort By:
Page
of 2
Memo
|
April 19, 2022
Agony of choice-selecting chronic lymphocytic leukemia treatment in 2022
Jan-Paul Bohn
Memo
|
September 18, 2018
Current and evolving treatment strategies in adult immune thrombocytopenia
Jan-Paul Bohn, Michael Steurer
Current Oncology Reports
|
September 8, 2023
Next-Generation Sequencing-Optimal Sequencing of Therapies in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
Florian Simon, Jan-Paul Bohn
Cancers
|
February 25, 2022
Treatment of Classic Hairy Cell Leukemia: Targeting Minimal Residual Disease beyond Cladribine
Jan-Paul Bohn, Sascha Dietrich
Memo
|
July 19, 2016
Long-term treatment of hairy cell leukemia with interferon-α: still a viable therapeutic option
Jan-Paul Bohn, Guenther Gastl, Michael Steurer
Targeted Oncology
|
January 30, 2016
Targeted Therapies for the Treatment of Brain Metastases in Solid Tumors
Jan-Paul Bohn, Georg Pall, Guenther Stockhammer, et al.
International Journal of Molecular Sciences
|
August 7, 2021
The Biology of Classic Hairy Cell Leukemia
Jan-Paul Bohn, Stefan Salcher, Andreas Pircher, et al.
Cancers
|
March 10, 2022
Hairy Cell Leukemia Patients Have a Normal Life Expectancy-A 35-Year Single-Center Experience and Comparison with the General Population
Jan-Paul Bohn, Sabrina Neururer, Markus Pirklbauer, et al.
Therapeutic Advances in Hematology
|
August 4, 2022
Major cardiac surgery with recombinant FIX Fc fusion protein replacement in hemophilia B: a case report
Jan-Paul Bohn, Anna Fiala, Sebastian Bachmann, et al.
Leukemia & Lymphoma
|
August 21, 2024
Reduced prognostic value of beta-2-microglobulin for time to first treatment in CLL patients with compromised kidney function
Jan-Paul Bohn, Valentina Stolzlechner, Georg Göbel, et al.
Page
of 2